Kite Pharma Inc. (KITE) Soared To A New High After Q4 Loss

Kite Pharma Inc. (KITE) reported a fourth quarter non-GAAP loss of $1.31 per share Tuesday morning, compared to the loss of $0.54 per share last year. The consensus estimate was for a loss of $1.75 per share.

from RTT - Before the Bell http://ift.tt/2m7FikC
via IFTTT